Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

Jimeno, A; Arcediano, A; Bazares, S; Amador, M L; González-Cortijo, L; Ciruelos, E; Robles, L; Castellano, D; Paz-Ares, L; Lumbreras, C; Hornedo, J; Cortés-Funes, H

Jimeno, A; Arcediano, A; Bazares, S; Amador, M L; González-Cortijo, L; Ciruelos, E; Robles, L; Castellano, D; Paz-Ares, L; Lumbreras, C; Hornedo, J; Cortés-Funes, H.

Affiliation

Jimeno A; Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. ajimeno1@jhmi.edu

Clin Transl Oncol ; 8(12): 889-95, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17169762

Subject(s)

Amikacin/administration & dosage; Anti-Bacterial Agents/therapeutic use; Ceftazidime/administration & dosage; Cephalosporins/therapeutic use; Neoplasms/drug therapy; Neutropenia/drug therapy; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cefepime; Drug Therapy, Combination; Female; Fever/drug therapy; Humans; Male; Middle Aged; Neutropenia/chemically induced; Stem Cell Transplantation; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Ceftazidime / Cephalosporins / Anti-Bacterial Agents / Neoplasms / Neutropenia Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Transl Oncol Year: 2006 Type: Article Affiliation country: Spain

Search on Google

XML

PubMed Links